MOG is a CNS-specific autoantigen expressed on the surface of mature oligodendrocytes and is targeted during the autoimmune CNS inflammation characteristic for MS (Dendrou et al. 2015; Breithaupt et al. 2003; Clements et al. 2003). This evidence concerns the gene MOG and myeloid sarcoma.